awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q37610714-FB70F95F-0734-4BEC-87C5-73F643558593
Q37610714-FB70F95F-0734-4BEC-87C5-73F643558593
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37610714-FB70F95F-0734-4BEC-87C5-73F643558593
Acute graft-versus-host disease: new treatment strategies.
P2860
Q37610714-FB70F95F-0734-4BEC-87C5-73F643558593
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37610714-FB70F95F-0734-4BEC-87C5-73F643558593
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
db06e238a35106764c415d76847e738c182db29e
P2860
A phase II multicenter study of visilizumab, humanized anti-CD3 antibody, to treat steroid-refractory acute graft-versus-host disease.